Browse resources

Region: Africa

Total results with these characteristics: 216

Page 2 of 9  
‹ prev.
1
2
3
4
5
next ›

Conjugate Vaccine Introduction in the African Meningitis Belt: Meeting Surveillance Objectives

This article, published in Tropical Medicine & International Health, asserts that surveillance systems and techniques for diagnosing bacterial meningitis and pneumococcal disease in the African meningitis belt have improved greatly over the …

Author: Mueller JE

Published: 2013

Cool Innovations for Vaccine Transportation and Storage

Keeping heat-sensitive vaccines and other drugs at the right temperature is crucial yet often difficult in areas with limited or no electrical power. This fact sheet describes a response to this challenge, where a group of public- and private-sector …

Author: PATH, World Health Organization

Published: 2012

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

Author: van Hoek AJ, Ngama M, Ismail A, et al.

Published: 2012

Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

Author: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A

Published: 2011

Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso

This article, published in Clinical Infectious Diseases, discusses an anthropologic and economic study in Burkina Faso to understand perceptions and behavior relative to meningitis and to determine the cost of illness from bacterial …

Author: Colombini A, Bationo F, Zongo S, et al.

Published: 2009

Costs of Meningitis Sequelae in Children in Dakar, Senegal

In economic evaluations of vaccines protecting against meningitis, treatment and productivity costs due to meningitis sequelae are rarely included in studies from low-income countries, mainly due to lack of data. This study, published in The …

Author: Griffiths UK, Dieye Y, Fleming J, Hajjeh R, Edmond K

Published: 2012

Critical Episodes in the Understanding and Control of Epidemic Meningococcal Meningitis

Epidemic meningococcal meningitis continues to be an important worldwide cause of morbidity and mortality, especially in developing countries. Throughout its history, a number of "critical episodes" have occurred that have enhanced understanding of …

Author: Artenstein AW, LaForce FM

Published: 2012

The Cure That Kills

This paper examines the health risks posed by unsafe injections in Africa and outlines some of the programs that are helping reduce these risks.

Author: Practical Patient Care

Published: 2008

Definition and Characterization of Localised Meningitis Epidemics in Burkina Faso: A Longitudinal Retrospective Study

The epidemiology of meningococcal meningitis in the African meningitis belt is characterized by seasonality, localized epidemics, and epidemic waves. To facilitate research and surveillance, the authors of this article, published in BMC Infectious …

Author: Tall H, Hugonnet S, Donnen P, et al.

Published: 2012

Delivering MenAfriVac Using the Controlled Temperature Chain Approach

In November 2012, the first immunization campaign to use a controlled temperature chain (CTC) took place in northern Benin. This photo set by project Optimize contains images taken during the campaign, where more than 155,000 people were vaccinated …

Author: PATH, World Health Organization

Published: 2013

Delivering Vaccines: A Cost Comparison of In-Country Vaccine Transport Container Options

Project Optimize undertook a cost-comparison case study of five container options for vaccine transport from the national to the regional level in Senegal. This report may be used as a starting point for other country vaccine programs weighing …

Author: PATH, World Health Organization

Published: 2013

Detecting Meningococcal Meningitis Epidemics in Highly-Endemic African Countries

This article, published in the World Health Organization's (WHO's) Weekly Epidemiological Record, provides the WHO recommendation for detecting and responding to meningococcal meningitis epidemics in highly-endemic countries in Africa. In each …

Author: World Health Organization

Published: 2000

Development and Implementation of a National Programme for the Management of Severe and Very Severe Pneumonia in Children in Malawi

This article, published in PLoS Medicine, provides an overview of the development and implementation of a national program for the management of severe and very severe childhood pneumonia in Malawi. Based on a successful delivery model used by the …

Author: Enarson PM, Gie R, Enarson DA, Mwansambo C

Published: 2009

Development of a Group A Meningococcal Conjugate Vaccine, MenAfriVac™

Group A meningococcal disease has been an important public health problem in sub-Saharan Africa for over a century. From 2003 to 2009 a monovalent group A conjugate vaccine, MenAfriVac™, was developed through an innovative public/private …

Author: Frasch C, Preziosi M-P, LaForce FM

Published: 2012

Domestic Refrigerators for Vaccine Storage in Tunisia: Conclusion and Recommendations

This project Optimize document summarizes a laboratory report on performance testing of four models of domestic refrigerators that are available on the Tunisian market. Project Optimize contracted the tests to demonstrate to the government the …

Author: PATH, World Health Organization

Published: 2012

Economic Evaluation of Delivering Haemophilus influenzae type b Vaccine in Routine Immunization Services in Kenya

This study, published in Bulletin of the World Health Organization, discusses the introduction of Hib vaccine in Kenya, one of the first nine countries to receive financial support from GAVI for Hib vaccine introduction. The objective of this study …

Author: Oloo Akumu A, Englisha M, Scott JAG, Griffiths UK

Published: 2007

An Economic Evaluation of Thermostable Vaccines in Cambodia, Ghana, and Bangladesh

This article, published in Vaccine, evaluates the incremental health and programmatic cost impacts of theoretical new vaccine products as compared to the standard vaccine products in multi-dose vials in Cambodia, Ghana, and Bangladesh. The authors …

Author: Levin A, Levin C, Kristensen D, Matthias D

Published: 2007

Effect of a Serogroup A Meningococcal Conjugate Vaccine (PsA—TT) on Serogroup A Meningococcal Meningitis and Carriage in Chad: A Community Study

A serogroup A meningococcal polysaccharide—tetanus toxoid conjugate vaccine (PsA—TT, MenAfriVac) was licensed in India in 2009, and prequalified by the World Health Organization in 2010, on the basis of its safety and immunogenicity. This …

Author: Daugla DM, Gami JP, Gamougam K, et al.

Published: 2013

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …

Author: Madhi SA, Cunliffe NA, Steele D, et al.

Published: 2010

Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience

In 2010, Burkina Faso conducted a country-wide campaign to introduce a new Group A meningococcal conjugate vaccine, MenAfriVac™. Leading up to this effort, the following challenges were successfully managed: (1) conducting a large safety study …

Author: Djingarey MH, Barry R, Bonkoungou M, et al.

Published: 2012

Efficacy of Nine-valent Pneumococcal Conjugate Vaccine Against Pneumonia and Invasive Pneumococcal Disease in The Gambia: Randomized Double-Blind, Placebo-Controlled Trial

Published in The Lancet, this study aims to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children through a randomised, placebo-controlled, double-blind trial in eastern Gambia. Children age 6–51 weeks were randomly …

Author: Cutts U, Zaman SMA, Enwere G, et al.

Published: 2005

Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Sub-Saharan Africa: A Randomised, Double-Blind, Placebo-Controlled Trial

This article, published in The Lancet, shares results of an efficacy study of the pentavalent, live oral rotavirus vaccine in Ghana, Kenya, and Mali. Results showed 39.3 percent efficacy against  severe rotavirus gastroenteritis. The authors …

Author: Armah GE, Sow SO, Breiman RF, et al.

Published: 2010

Efficacy of RTS,S/AS01E Vaccine Against Malaria in Children 5 to 17 Months of Age

This study, published in the New England Journal of Medicine, evaluated the efficacy of the RTS,S malaria vaccine given with a more immunogenic adjuvant system (AS01E) than one used in a previous study (AS02A). The study was conducted in …

Author: Bejon P, Lusingu J, Olotu A, et al.

Published: 2008

Eliminating Epidemic Group A Meningococcal Meningitis in Africa Through a New Vaccine

This article, published in Health Affairs, discusses a new affordable vaccine against Group A meningococcus, the most common cause of large and often fatal African epidemics of meningitis, that was introduced in Burkina Faso, Mali, and Niger in …

Author: LaForce FM, Okwo-Bele J-M

Published: 2011

Elimination of Haemophilus influenzae type b (Hib) Disease From The Gambia After the Introduction of Routine Immunisation With a Hib Conjugate Vaccine: A Prospective Study

Routine immunization of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May 1997. This article, published in The Lancet, reports on a study that investigated the effectiveness …

Author: Adegbola RA, Secka O, Lahai G, et al.

Published: 2005

Page 2 of 9  
‹ prev.
1
2
3
4
5
next ›